Overview

Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia

Status:
RECRUITING
Trial end date:
2029-02-01
Target enrollment:
Participant gender:
Summary
BMT CTN 2207 will investigate the use of marrow transplantation for treatment of severe aplastic anemia that has not previously been treated.
Phase:
PHASE2
Details
Lead Sponsor:
Medical College of Wisconsin
Collaborators:
National Cancer Institute (NCI)
National Heart, Lung, and Blood Institute (NHLBI)
Sanofi